Today: 8 June 2026
Browse Category

NASDAQ:DVAX 24 August 2025 - 24 December 2025

Dynavax Technologies (DVAX) Stock After the Bell on Dec. 24, 2025: Sanofi’s $2.2B Buyout, After‑Hours Action, and What to Watch Before the Next Market Open

Dynavax Technologies (DVAX) Stock After the Bell on Dec. 24, 2025: Sanofi’s $2.2B Buyout, After‑Hours Action, and What to Watch Before the Next Market Open

Sanofi agreed to acquire Dynavax Technologies for $15.50 per share in cash, valuing the deal at about $2.2 billion. DVAX shares surged 39% to around $15.45, trading near the offer price after the announcement. Volume topped 30 million shares in a volatile session shortened for the holiday. The transaction is expected to close in Q1 2026, pending customary conditions.
24 December 2025
··
Intel Stock Slides as Nvidia Pauses 18A Testing; Nike Jumps on Tim Cook Buy and Dynavax Soars on Sanofi Deal

Intel Stock Slides as Nvidia Pauses 18A Testing; Nike Jumps on Tim Cook Buy and Dynavax Soars on Sanofi Deal

Intel shares fell up to 3.9% after reports said Nvidia halted testing of Intel’s 18A chipmaking process. Nike rose after Apple CEO Tim Cook disclosed a $3 million purchase of Nike stock. Dynavax Technologies surged after Sanofi agreed to acquire the company for $2.2 billion. The S&P 500 hovered near record highs in quiet, holiday-shortened trading.
24 December 2025
····
Dynavax Technologies (DVAX) Stock Jumps on Sanofi’s $2.2B Cash Buyout Offer: Latest News, Forecasts, and What Comes Next (Dec. 24, 2025)

Dynavax Technologies (DVAX) Stock Jumps on Sanofi’s $2.2B Cash Buyout Offer: Latest News, Forecasts, and What Comes Next (Dec. 24, 2025)

Sanofi announced a deal to acquire Dynavax Technologies for $2.2 billion in cash, offering $15.50 per share—a 39% premium to Dynavax’s prior close. DVAX stock jumped about 37% premarket to near the offer price. Dynavax’s board approved the transaction. Closing is expected in Q1 2026, pending regulatory and shareholder approvals.
24 December 2025
···
EU Stock Markets Today (24 December 2025): STOXX 600 Flat on Christmas Eve as BP Castrol Deal, Sanofi’s Dynavax Move and Record Metals Set the Tone

EU Stock Markets Today (24 December 2025): STOXX 600 Flat on Christmas Eve as BP Castrol Deal, Sanofi’s Dynavax Move and Record Metals Set the Tone

The STOXX 600 index was flat at 588.93 by 08:09 GMT on December 24, 2025, as EU stock markets saw sharply reduced liquidity with Germany and Italy closed and other exchanges running shortened sessions for Christmas Eve. Energy shares rose on firmer oil, while miners tracked gains in precious metals. Trading volumes were thin across the continent.
24 December 2025
···
Breakthrough Cures, Billion-Dollar Bets & Health Shockers – Global Biotech & Health News Roundup (Aug 23–24, 2025)

Breakthrough Cures, Billion-Dollar Bets & Health Shockers – Global Biotech & Health News Roundup (Aug 23–24, 2025)

The FDA cleared Rocket Pharma to resume its gene therapy trial for Danon disease after a patient death halted the study in May; the trial will restart with a lower dose and without the immune-suppressing drug linked to the fatal complication. Rocket shares jumped over 30% after the decision. Early data showed Dynavax’s shingles vaccine matched GSK’s Shingrix in immune response but caused fewer side effects, sending Dynavax shares up 7%.
24 August 2025
···

Stock Market Today

  • AMD Stock Prediction: Can Shares Hit $650 by 2027 Amid Strong Data Center Growth?
    June 8, 2026, 2:54 PM EDT. Advanced Micro Devices (AMD) posted 57% revenue growth in its Data Center segment and a 253% surge in free cash flow, driving a bull case for shares to reach $650 by 2027. Current Wall Street consensus targets $482, seen as conservative given AMD's momentum. Achieving $650 requires sustained 50%+ Data Center growth and upward earnings per share (EPS) revisions supporting a 95x forward price-to-earnings (P/E) multiple. Geopolitical risks persist, notably U.S. export controls on China, which cost AMD $440 million in fiscal 2025 and could limit upside. The stock's volatility, with a beta of 2.49, has prompted recent profit-taking after a 303% one-year gain. Analysts are mostly bullish, with 80% recommending buy or strong buy ratings.

Latest articles

Nu Shares Drop, $1 Billion Buyback Doesn’t Ease Market

Nu Shares Drop, $1 Billion Buyback Doesn’t Ease Market

8 June 2026
Nu Holdings shares slid 3.1% to $11.60 as investors weighed CFO transition risks and rising credit costs, erasing last week’s 4.1% buyback-driven bounce; BofA downgraded the stock to Underperform with a $10 target, citing uncertainty from Lago’s exit, while Nu’s $1B buyback failed to stem a 10.7% weekly drop and 30.7% year-to-date decline, leaving shares just above their 52-week low.
Inno Holdings Soared Nearly 20 Times—AI Deal Includes a Caveat

Inno Holdings Soared Nearly 20 Times—AI Deal Includes a Caveat

8 June 2026
Inno Holdings shares soared twentyfold to $20.97 after announcing a $3 million AI sales agent deal for its used mobile phone business, but investor risks remain with a recent $60 million at-the-market stock program and ongoing going-concern warnings in filings, as the project is still in early development and not yet commercially launched.
Emirates Cuts A380 Flights, Raising Concerns Over Summer Airfare

Emirates Cuts A380 Flights, Raising Concerns Over Summer Airfare

8 June 2026
Emirates slashed June A380 flights on 10 major routes as soaring fuel costs and Middle East airspace disruption forced airlines to cut capacity, prompting IATA to halve its 2026 global profit forecast to $23 billion from $41 billion, with industry-wide seat reductions and rising fares expected as carriers struggle to absorb shocks during peak travel.
Wall Street Watches Microsoft’s $37 Billion AI Bet

Wall Street Watches Microsoft’s $37 Billion AI Bet

8 June 2026
Microsoft shares fell 1.5% to $410.30 as investors weighed bullish analyst calls and NHS England’s Copilot rollout against concerns that surging AI revenue—now at a $37 billion run rate—may not outpace rising costs and margin pressure from heavy infrastructure investment.
Cerebras shares jump as Wall Street eyes AI chipmaker’s Nvidia bid

Cerebras shares jump as Wall Street eyes AI chipmaker’s Nvidia bid

8 June 2026
Cerebras shares soared about 20% to $241.44 after Wall Street analysts initiated coverage post-IPO, citing rapid demand for fast AI inference and partnerships with OpenAI and AWS; Needham set a $300 price target, while the average analyst forecast reached $295, as chip stocks broadly rebounded and the PHLX Semiconductor Index jumped over 6%.
Go toTop